U.S. Pharmaceuticals & Biotech Most Popular Stocks

Goodbody Health

Market Cap: US$36.0

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

ARYx Therapeutics

Market Cap: US$33.0

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Genvor

Market Cap: US$29.0

Develops plant-based defense technology designed to help farmers achieve global food security.

FluoroPharma Medical

Market Cap: US$27.0

A biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States.

Anthera Pharmaceuticals

Market Cap: US$26.0

A biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.

Verde Science

Market Cap: US$23.0

A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.

Regnum

Market Cap: US$22.0

Develops and commercializes therapeutics that treat rare and infectious diseases.

Corix Bioscience

Market Cap: US$20.0

Provides cannabidiol (CBD) oil for various medicinal purposes.

VIA Pharmaceuticals

Market Cap: US$20.0

A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.

Affimed

Market Cap: US$16.0

A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.

Tibet Pharmaceuticals

Market Cap: US$14.0

A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.

IMV

Market Cap: US$14.0

Operates as a clinical-stage immuno-oncology company.

BG Medicine

Market Cap: US$11.0

Engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States.

Adhera Therapeutics

Market Cap: US$11.0

A biotech company, focuses on the discovery, development, and commercialization of small molecule drugs.

Proteonomix

Market Cap: US$7.0

A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.

VioQuest Pharmaceuticals

Market Cap: US$6.0

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases.

Stem Holdings

Market Cap: US$6.0

Does not have significant operations.

Adynxx

Market Cap: US$5.0

A clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases.

Acusphere

Market Cap: US$4.0

Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.

Synvista Therapeutics

Market Cap: US$2.0

A product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease.

Cannalink

Market Cap: US$0

A development stage company that intends to develop cannabidiol based products and provide services to emerging companies in the medical marijuana and industrial healthcare sector.

G-H-3 International

Market Cap: US$0

Develops products for addressing factors, which cause aging and deterioration in the body.